PNEUDOMVI
LIVE

Serial Number

98271201

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Nov 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PNEUDOMVI Trademark

Serial Number: 98271201 • Registration: 7594883

PNEUDOMVI is a trademark filed by GlaxoSmithKline Biologicals SA on November 15, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

November 15, 2023

Registration Date

December 10, 2024

Published for Opposition

October 8, 2024

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 25, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2024 NWOS
NEW APPLICATION ENTERED
Nov 15, 2023 NWAP